Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)

Topics

Chemistry

Biochemistry

Medicine

Pathology

Internal Medicine

Show all topics

DOI

10.3950/jibiinkotokeibu.127.11_1187